The follow-up of patients after the combination therapy with inactivated nevus and cultured epidermal autograft and the efficacy of the ruby laser irradiation to remove the residual melanin pigment

The follow-up of patients after the combination therapy with inactivated nevus and cultured epidermal autograft and the efficacy of the ruby laser irradiation to remove the residual melanin pigment - The follow-up of patients after the combination therapy and the efficacy of the ruby laser irradiation

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020908

Enrollment

Registered

2016-02-08

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital melanocytic nevi

Interventions

The ruby laser irradiation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients who received the combination therapy and have the take of inactivated nevus. 2.Written informed consent

Exclusion criteria

Exclusion criteria: 1.Patients with no take of the inactivated nevus 2.Patients who have been judged not to be appropriate for this study

Design outcomes

Primary

Measure	Time frame
The recurrence of nevus 1 year after the reconstruction	—

Secondary

Measure	Time frame
Adverse events	—

Countries

Japan

Contacts

Public ContactMiyuki Omura

Kansai Medical University Center for Clinical Research

kmuccr@hirakata.kmu.ac.jp072-804-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026